drugset / Trial / NCT02019251

Lung Transplant Subjects Using 19F MRI

NCT02019251 ↗

Phase 1 Completed 6 enrolled Hal C Charles
NaSingle-groupOpen-labelDiagnostic

Summary

The goal of this study is to evaluate the utilization of conventional 'thermally' polarized perfluorinated gases mixed with oxygen as inhaled inert contrast agents to image the airway spaces in subjects who have undergone single or double lung transplantation. This is an open label study expanding on current work here at Duke. Images will be obtained using 19F MRI during wash-in and washout for evaluation of ventilation efficiency.

Timeline

Start
2013-12
Primary completion
2014-06
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject perfluorinated gas/oxygen mixture Diagnostic / imaging agent 20000 ml Inhaled

Indications

No indication recorded.